Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...

AI can help protein engineers optimize the transcription enzymes used to make mRNA-based vaccines and therapeutics, say the authors of a new study.

In a new study, published in Cell, researchers describe a newfound mechanism for creating proteins in a giant DNA virus, ...

Three-letter DNA “words” can decide whether a yeast cell cranks out a medicine efficiently or sputters along. The words are ...

According to Precedence Research, the global RNA analysis market size is expected to be worth USD 23.39 billion by 2035, increasing from USD 10.21 billion in 2026, with a strong CAGR of 9.65% from ...

Global mRNA Synthesis and Manufacturing Market OverviewThe global mRNA synthesis and manufacturing market is projected to grow at a compound annual growth rate of approximately 6% during the forecast ...

Nucleotide synthesis—the production of the basic components of DNA and RNA—is essential for cell growth and division. In most ...

A new study shows lipid nanoparticles can be formulated at much higher lipid concentrations using a modular mixing approach, improving in vivo performance, stability, and scalability.

In a recent study published in the Proceedings of the National Academy of Sciences (PNAS), researchers at the Texas A&M University Health Science Center (Texas A&M Health) identify a novel RNA ...

Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful compounds. In a new study, MIT chemical engineers have harnessed artificial ...

(LEON) has closed a financing round designed to help meet rising demand for scalable nanoparticle manufacturing technologies.

A major international study shows that increasing a naturally occurring molecule can help restore memory in animal models of ...